Correlation Between Taigen Biopharmaceutica and MiTAC Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Taigen Biopharmaceutica and MiTAC Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taigen Biopharmaceutica and MiTAC Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taigen Biopharmaceuticals Holdings and MiTAC Holdings Corp, you can compare the effects of market volatilities on Taigen Biopharmaceutica and MiTAC Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taigen Biopharmaceutica with a short position of MiTAC Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taigen Biopharmaceutica and MiTAC Holdings.

Diversification Opportunities for Taigen Biopharmaceutica and MiTAC Holdings

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Taigen and MiTAC is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Taigen Biopharmaceuticals Hold and MiTAC Holdings Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiTAC Holdings Corp and Taigen Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taigen Biopharmaceuticals Holdings are associated (or correlated) with MiTAC Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiTAC Holdings Corp has no effect on the direction of Taigen Biopharmaceutica i.e., Taigen Biopharmaceutica and MiTAC Holdings go up and down completely randomly.

Pair Corralation between Taigen Biopharmaceutica and MiTAC Holdings

Assuming the 90 days trading horizon Taigen Biopharmaceuticals Holdings is expected to under-perform the MiTAC Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Taigen Biopharmaceuticals Holdings is 2.42 times less risky than MiTAC Holdings. The stock trades about -0.33 of its potential returns per unit of risk. The MiTAC Holdings Corp is currently generating about 0.43 of returns per unit of risk over similar time horizon. If you would invest  4,500  in MiTAC Holdings Corp on August 30, 2024 and sell it today you would earn a total of  3,880  from holding MiTAC Holdings Corp or generate 86.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Taigen Biopharmaceuticals Hold  vs.  MiTAC Holdings Corp

 Performance 
       Timeline  
Taigen Biopharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taigen Biopharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
MiTAC Holdings Corp 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in MiTAC Holdings Corp are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, MiTAC Holdings showed solid returns over the last few months and may actually be approaching a breakup point.

Taigen Biopharmaceutica and MiTAC Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Taigen Biopharmaceutica and MiTAC Holdings

The main advantage of trading using opposite Taigen Biopharmaceutica and MiTAC Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taigen Biopharmaceutica position performs unexpectedly, MiTAC Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiTAC Holdings will offset losses from the drop in MiTAC Holdings' long position.
The idea behind Taigen Biopharmaceuticals Holdings and MiTAC Holdings Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings